2 news items
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
VERV
8 May 24
; expectations for the company's Heart-1 clinical trial, including the company's assessment of the laboratory abnormalities observed in the trial
Verve Therapeutics Announces Updates on its PCSK9 Program
VERV
2 Apr 24
, including the company's assessment of the laboratory abnormalities observed in the trial and the company's interactions with regulatory authorities regarding
- Prev
- 1
- Next